Cargando…
A proof-of-concept study for the design of a VLP-based combinatorial HPV and placental malaria vaccine
In Africa, cervical cancer and placental malaria (PM) are a major public health concern. There is currently no available PM vaccine and the marketed Human Papillomavirus (HPV) vaccines are prohibitively expensive. The idea of a combinatorial HPV and PM vaccine is attractive because the target popula...
Autores principales: | Janitzek, Christoph M., Peabody, Julianne, Thrane, Susan, H. R. Carlsen, Philip, G. Theander, Thor, Salanti, Ali, Chackerian, Bryce, A. Nielsen, Morten, Sander, Adam F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437161/ https://www.ncbi.nlm.nih.gov/pubmed/30918267 http://dx.doi.org/10.1038/s41598-019-41522-5 |
Ejemplares similares
-
RNA Phage VLP-Based Vaccine Platforms
por: Peabody, David S., et al.
Publicado: (2021) -
Characterization of a spray-dried candidate HPV L2-VLP vaccine stored for multiple years at room temperature
por: Peabody, Julianne, et al.
Publicado: (2017) -
A Novel Virus-Like Particle Based Vaccine Platform Displaying the Placental Malaria Antigen VAR2CSA
por: Thrane, Susan, et al.
Publicado: (2015) -
A Pan-HPV Vaccine Based on Bacteriophage PP7 VLPs Displaying Broadly Cross-Neutralizing Epitopes from the HPV Minor Capsid Protein, L2
por: Tumban, Ebenezer, et al.
Publicado: (2011) -
The Immunogenicity of a VLP-based Malaria Vaccine Targeting CSP in Pregnant and Neonatal Mice
por: Jelínková, Lucie, et al.
Publicado: (2023)